Cancer Drug Resistance
All Journals
Search Log In
Home Articles Special Issues Volumes Webinars Videos
Cancer Drug Resistance
Search Submit
Home Articles Special Issues Volumes Webinars Videos

fig6

From:  Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy

Figure 6. Overall survival is shorter in BC patients with higher TCTP expression. Kaplan-Meier analysis of overall survival in BC patients based on KM plotter database of: (A) PAM50 HER2 and (B) PAM50 basal subtypes. BC: Breast cancers; HER2: human epidermal growth factor receptor-2; TCTP: translationally controlled tumor protein; TPT1: tumor protein, translationally-controlled 1.

Cancer Drug Resistance
ISSN 2578-532X (Online)
Navigation
Follow Us
Navigation

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Committee on Publication Ethics

https://members.publicationethics.org/members/cancer-drug-resistance

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/
Discover Content
Follow OAE
Twitter
Facebook
LinkedIn
YouTube
BiLiBiLi
WeChat
© 2016-2025 OAE Publishing Inc., except certain content provided by third parties